Home » Topics » Disease categories and therapies » Musculoskeletal

Musculoskeletal
RSS

Novel caspase inhibitors and their use reported by Vertex

Jan. 7, 2003

COX-2-specific inhibitor LAS-34475 compares favorably to naproxen in osteoarthritis

Jan. 7, 2003

Humira approved by FDA for RA

Jan. 3, 2003

Genelabs submits MAA for lupus drug in Europe

Jan. 3, 2003

Novel p38 kinase inhibitors prepared and tested at Teikoku Hormone

Jan. 2, 2003

Axovan enters research collaboration with Biolipox to discover antiinflammatory drugs

Dec. 30, 2002

Novel inhibitors of cytokine production covered by Boehringer Ingelheim patent

Dec. 27, 2002

Recent discovery of macrophage-inhibitory compounds by Sankyo researchers

Dec. 23, 2002

Celecoxib filed for approval in Japan by Pharmacia and Yamanouchi

Dec. 23, 2002

New inhibitors of JNK3, Src and/or Lck kinases in early development at Vertex

Dec. 20, 2002

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 24, 2026.
Brain-penetrant NLRP3 inhibitor shows promise in Parkinson’s
BioWorld Science
Researchers from Changchun Genescience Pharmaceuticals Co. Ltd. described the discovery and preclinical profile of an NLRP3 inhibitor with favorable brain...
4D Nucleome opens new wave of gene regulation research, discovery
BioWorld
After a decade of research, the NIH 4D Nucleome program on July 23 delivered a wealth of new insights into how spatial changes in chromatin structure and DNA...
Transcripta Bio raises funding to advance neuro pipeline
BioWorld Science
Transcripta Bio Inc. has raised $24 million since its series A to fund IND-enabling studies across its portfolio and support clinical preparation in its autism...
Daybu readthrough in EU? Zevra’s NPC bid flounders
BioWorld
Zevra Therapeutics Inc. will try to follow in the footsteps of Acadia Pharmaceuticals Inc. with Rett syndrome drug Daybu (trofinetide) by asking the EMA’s...